Endologix, Inc. reaffirmed earnings guidance for the full year and provides earnings guidance for the fourth quarter ending December 31, 2019. For the year, the company reaffirmed it previously issued guidance and continues to expect 2019 revenue of at least $140 million. The Company anticipates revenue for the fourth quarter ending December 31, 2019 in the range of $32.5 million to $35.5 million.